International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationEarly Expansion of the Intracranial CSF Volume After Palliative Whole-Brain Radiotherapy: Results of a Longitudinal CT Segmentation Analysis
Introduction
Palliative whole-brain radiotherapy (WBRT) represents the standard of care for many patients with brain metastases (1). For most patients, survival is short. Nevertheless, a subset of patients (recursive partitioning analysis Class 1) have been identified, some of whom can be expected to survive for years (2). Preventing decline in neurocognitive function, a possible consequence of cerebral atrophy, is an important goal for these long-term survivors, particularly in view of the correlation with quality of life (3). Concerns regarding radiation toxicity have prompted recommendations for conformal radiotherapeutic techniques, such as radiosurgery, and the avoidance of WBRT whenever possible 4, 5. This argument was supported by a recently presented randomized study from M. D. Anderson Cancer Center (Houston, TX) evaluating WBRT and radiosurgery vs. radiosurgery alone (6). Chang found a significant decline in neurocognitive function at 4 months within the combined arm. Nevertheless, WBRT can improve intracranial disease control (7) and may prevent tumor-related early loss of neurocognitive function 8, 9, 10.
To date, research into the neurocognitive decline in patients with brain tumors has focused on the serial administration of rating scales for cognitive function 8, 9, 10, 11. Though very informative, the interpretation of results can be confounded by recurrent tumor and the administration of additional treatments such as chemotherapy and reirradiation. Our study has adopted a complementary approach by focusing on morphologic changes in the brain after a commonly prescribed palliative radiation dose prescription. The method selected was a segmentation technique previously developed to segment images of patients with dementia from other causes. Published normal-population data were used as a control (12).
Section snippets
Methods and Materials
Patients with a single brain metastasis completing WBRT (30 Gy in 10 fractions over a period of 2 weeks) with at least 3 years of computed tomography (CT) follow-up, within a single institution, were identified from a database of 799 consecutive consultations for patients referred with brain metastases between July 1990 and September 2003. Whole-brain irradiation was delivered by use of a parallel opposed pair of lateral whole-brain ports with the radiation dose prescribed at the midplane on
Results
Nine patients (five women and four men) met the inclusion criteria for the study. A total of 103 CT scans were performed on these patients, but 9 were unsuitable for segmentation analysis and excluded. Exclusions were because of missing axial slices or poor-quality images, which did not permit accurate discrimination between tissues. The median number of CT scans analyzed per patient was 9 (range, 5–16). The median number of CT slices segmented per scan was 18, and a total of 1,782 segmented
Discussion
This study has shown that WBRT immediately accelerates the rate at which the ICSFV percentage increases over time. It should be noted, however, that ICSFV is a relatively small intracranial compartment and the corresponding percentage reductions in the volume of brain parenchyma (cerebral atrophy) are proportionately less.
Age-associated brain atrophy was initially confirmed through autopsies (14). Segmentation studies subsequently quantified the rate of age-related atrophy, confirming an
Acknowledgments
We are grateful to Anne Martel (Imaging Research Scientist, Sunnybrook Health Sciences Centre) for her guidance on the image segmentation methodology used in this study and for comments on the final manuscript. In addition, we thank Mike Bronskill (Imaging Research, Sunnybrook Health Sciences Centre), who helped to make the segmentation software available.
References (32)
- et al.
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Int J Radiat Oncol Biol Phys
(1997) - et al.
Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis
Int J Radiat Oncol Biol Phys
(2008) - et al.
Radiosurgery for brain metastases: Is whole brain radiotherapy necessary?
Int J Radiat Oncol Biol Phys
(1999) - et al.
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
Int J Radiat Oncol Biol Phys
(2002) - et al.
Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone
Int J Radiat Oncol Biol Phys
(2007) - et al.
Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from radiation therapy oncology group study 91-04
Int J Radiat Oncol Biol Phys
(2001) - et al.
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on radiation therapy oncology group (RTOG) trial 0118
Int J Radiat Oncol Biol Phys
(2008) - et al.
Changes in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study
Lancet
(2003) - et al.
Structural magnetic resonance imaging in the practical assessment of dementia: Beyond exclusion
Lancet Neurol
(2002) - et al.
Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies
Int J Radiat Oncol Biol Phys
(2007)
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Cell
Radiotherapy of the brain in elderly patients. Contra
Eur J Cancer
Whole brain radiotherapy for the treatment of multiple brain metastases
Cochrane Database Syst Rev
Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial
JAMA
Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function
J Clin Oncol
Cited by (9)
Total-Body Irradiation Alters White Matter Volume and Microstructural Integrity in Rhesus Macaques
2023, International Journal of Radiation Oncology Biology PhysicsTwo-staged gamma knife radiosurgery for treatment of numerous (>10) brain metastases
2020, Clinical Neurology and NeurosurgeryCitation Excerpt :Perilesional normal tissue irradiation increases when too many lesions are irradiated, which should result in more treatment-related complications. However, applying WBRT instead of GKS is also debatable because of its side effects such as decline in neurocognitive functions, adverse effects in quality of life measures, or increase in cerebral atrophy [27,28], and time-consuming treatment course. There are several limitations to this study.
Neurocognitive Effects Following Cranial Irradiation for Brain Metastases
2015, Clinical OncologyCitation Excerpt :Data describing neurocognitive effects more than 6 months after WBRT for brain metastases are scant and limited by high dropout rates and confounding factors. An imaging study of nine long-term survivors with a median survival of 6.25 years showed acceleration in the rate of cerebral atrophy after WBRT compared with normal aging [28] but correlation with NCF was not reported. Some evidence suggests early detrimental effects may improve at later time points.
Prophylactic cranial irradiation (PCI). Still a no-brainer?
2015, Lung CancerIntracranial radiosurgery in three or more brain metastases - therapeutic schemes and results
2021, Rentgenologiya i Radiologiya
P.S. was supported by The Peters Fellowship in Brain Tumour Clinical Care and Research. S.L.G. and P.S. were supported by donations from W. Ren and D. Molson to the CNS Site Group at the Odette Cancer Centre.
Conflict of interest: none.